ESR2 and prostate cancer: In recent years, the therapeutic potential of estrogen receptor beta (ERβ) in breast cancer, prostate cancer, lung cancer, the nervous system, and bone tissue has been revealed, and this target has attracted more and more attention [1,2,3,4].